Glenmark launches Akynzeo in India under licensing pact with Helsinn

Glenmark Pharmaceuticals today launched Akynzeo, a drug used for prevention chemotherapy-induced nausea and vomiting, in India and Nepal.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news